<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02897193</url>
  </required_header>
  <id_info>
    <org_study_id>ABT-ME-130815</org_study_id>
    <nct_id>NCT02897193</nct_id>
  </id_info>
  <brief_title>Central Incisors Narrow Implants in Alternative to Bone Augmentation With 4.2 mm Implants .</brief_title>
  <official_title>3.2 mm Diameter Implants and Soft Tissue Grafts in Alternative to Horizontal Bone Augmentation for Placing 4.2 mm Diameter Implants at Central Incisors. A Multicenter Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alpha - Bio Tec Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alpha - Bio Tec Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Horizontal bone augmentation procedures are commonly used to increase bone width to allow the
      placement of dental implants or to improve aesthetics in deficient areas. Smaller diameter
      implants could be used instead in order to avoid bone augmentation procedures.

      The comparison between these two solutions will be evaluated in the trial.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>bone loss</measure>
    <time_frame>2 years</time_frame>
    <description>bone loss level as will be measured from the radio-graphic images</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative implant survival</measure>
    <time_frame>2 years</time_frame>
    <description>Counting number of survived implants at the end of the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Upper Central Incisor Edentulism</condition>
  <arm_group>
    <arm_group_label>Dental implant with bone augmentation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will be installed with ICE Dental implant 4.2 mm diameter with Alpha-Bio's grafts horizontal bone augmentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>narrow implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will be installed with NICE Dental implant 3.2 mm diameter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICE dental implant 4.2 mm</intervention_name>
    <description>ICE dental implant 4.2 mm diameter</description>
    <arm_group_label>Dental implant with bone augmentation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NICE dental implant 3.2 mm</intervention_name>
    <description>NICE dental implant 4.2 mm diameter</description>
    <arm_group_label>narrow implant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alpha Bio's Graft Bovine bone</intervention_name>
    <description>Alpha Bio's Graft Bovine Bone</description>
    <arm_group_label>Dental implant with bone augmentation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alpha Bio's Graft resorbable membrane</intervention_name>
    <description>Alpha Bio's Graft resorbable collagen membrane</description>
    <arm_group_label>Dental implant with bone augmentation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Upper central incisor edentulism

          -  bone width between 3.5-4.5 mm

          -  requirement of only one implant supported crown

          -  patient is willing to sign an informed consent

        Exclusion Criteria:

          -  General contraindications to implant surgery.

          -  Immunosuppressed or immunocompromised patients

          -  Patients irradiated in the head and neck area.

          -  Patients with poor oral hygiene and motivation.

          -  Uncontrolled diabetes.

          -  Pregnancy or lactation.

          -  Addiction to alcohol or drugs.

          -  Untreated periodontal disease.

          -  Treated or under treatment with intravenous amino-biphosphonates.

          -  Poor oral hygiene and motivation.

          -  Psychiatric problems and/or unrealistic expectations.

          -  Acute infection (abscess) or suppuration in the area intended for implant placement.

          -  Patients referred only for implant placement if cannot be followed at the treatment
             centre.

          -  Patient unable to attend the follow-up controls for 3 years after implant loading.

          -  Patient included in other studies, if this protocol cannot be properly followed.

          -  Immediate post-extractive sites (to be eligible at least 3 months must have passed
             since extraction).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Antofagasta</name>
      <address>
        <city>Antofagasta</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Andr√©s Bello National University</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <link>
    <url>http://www.alpha-bio.net</url>
    <description>sponsor site</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2016</study_first_submitted>
  <study_first_submitted_qc>September 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2016</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

